FDA
-
-
-
-
-
-
-
Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial
-
-
-
-
-
-
-
Adial Pharmaceuticals completes genetic test validation with Genomind
-
-
-
-
-
-
-
Adial Pharmaceuticals completes FDA meeting for AD04 phase 3 trial
-
-
-
-
-
-
-
Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Adial Pharmaceuticals Announces Positive Clinical Study Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
-
-
-
-
-
-
-
Adial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
-
334,273 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


